Mubadala-backed Kelix Bio seals MENA insulin manufacturing deal
January 16, 2025 Dubai-headquartered Kelix Bio, wholly owned by Abu Dhabi’s Mubadala Investment (Mubadala), has completed the acquisition of insulin manufacturer DiabTec, a subsidiary...